Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | PRCP | P42785 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7436023 | 0.95 | DRD2 (0.49) | DRD2HSD11B1PRCPIDO1 | |
| SCHEMBL16635558 | 0.92 | DRD2 (0.49) | DRD2HSD11B1PRCP | |
| SCHEMBL15139479 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A | |
| SCHEMBL18032810 | 0.92 | DRD2 (0.51) | DRD2HSD11B1PRCP | |
| SCHEMBL15139476 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A | |
| SCHEMBL9963997 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A | |
| SCHEMBL1865836 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A | |
| SCHEMBL1870363 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A | |
| SCHEMBL22260050 | 0.92 | DRD2 (0.51) | DRD2HSD11B1PRCP | |
| SCHEMBL1865834 | 0.92 | DRD2 (0.59) | DRD2HSD11B1PRCPADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160244433-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-08-25 | — | — | US | claimed |
| EP-3055296-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2016-08-17 | — | — | EP | claimed |
| WO-2015052160-A9 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-09-17 | — | — | WO | claimed |
| WO-2015052160-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-04-16 | — | — | WO | claimed |
| US-10626109-B2 | N-hetaryl(thio)carbonyl-2-(benzocycloalken-1-yl)cyclamines and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-04-21 | — | — | US | disclosed |
| US-20160244433-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-08-25 | — | — | US | disclosed |
| EP-3055296-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2016-08-17 | — | — | EP | disclosed |
| WO-2015052160-A9 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015052160-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626109-B2 | N-hetaryl(thio)carbonyl-2-(benzocycloalken-1-yl)cyclamines and their use as fungicides | CBR1, CBR3, CYP4Z1 | DRD2 966/4885HSD11B1 1112/4885PRCP 3987/4885 |
| US-20160244433-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | CBR1, CBR3, CYP4Z1 | DRD2 966/4885HSD11B1 1112/4885PRCP 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.